← Leaderboards
Sandra Demaria
New York University School Of Medicine
$8,493,423
Attributed
$8,493,423
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,493,423 · 6
By mechanism
R01$7,466,774 · 3
K08$684,450 · 1
R21$237,724 · 1
S10$104,475 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Jane Amanda Skok$18,379,753
- George Miller$7,866,873
- Catherine Sibyl Diefenbach$4,196,638
- Kelsey R Monson$170,583
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorRadiationMediatingT-LymphocyteImmuneImmunotherapyRadiation TherapyNeoplasm MetastasisIn VivoDendritic CellsCancer PatientAntigensTumor AntigensT Cell ResponseCd8b1 GeneImmunogenicCancer TherapyResponseNeoplastic CellMutationSiteCarcinomaCancer CellProteins
Grant awards (27)
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation$810,359
R01 · FY2025 · CA · contact PI
Precision use of radiation for in situ cancer immunization$237,724
R21 · FY2025 · CA · contact PI
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation$384,921
R01 · FY2024 · CA · contact PI
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation$397,076
R01 · FY2023 · CA · contact PI
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation$405,180
R01 · FY2022 · CA · contact PI
Hypoxic incubator for physiological cell culture research$104,475
S10 · FY2022 · OD · contact PI
Individualized in situ vaccination by radiation and immunotherapy$387,732
R01 · FY2020 · CA · contact PI
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation$387,731
R01 · FY2020 · CA · contact PI
Individualized in situ vaccination by radiation and immunotherapy$376,098
R01 · FY2019 · CA · contact PI
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation$376,098
R01 · FY2019 · CA · contact PI
Individualized in situ vaccination by radiation and immunotherapy$387,731
R01 · FY2018 · CA · contact PI
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation$387,731
R01 · FY2018 · CA · contact PI
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation$387,731
R01 · FY2017 · CA · contact PI
Individualized in situ vaccination by radiation and immunotherapy$387,731
R01 · FY2017 · CA · contact PI
Individualized in situ vaccination by radiation and immunotherapy$405,106
R01 · FY2016 · CA · contact PI
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation$387,731
R01 · FY2016 · CA · contact PI
Local Radiation as an Adjuvant for Immunotherapy$312,389
R01 · FY2011 · CA · contact PI
Local Radiation as an Adjuvant for Immunotherapy$322,050
R01 · FY2010 · CA · contact PI
Local Radiation as an Adjuvant for Immunotherapy$322,050
R01 · FY2009 · CA · contact PI
Local Radiation as an Adjuvant for Immunotherapy$322,050
R01 · FY2008 · CA · contact PI
Local Radiation as an Adjuvant for Immunotherapy$319,279
R01 · FY2007 · CA · contact PI
TUMOR APOPTOSIS AS MAJOR DETERMINANT OF IMMUNOGENICITY$68,445
K08 · FY2006 · CA · contact PI
TUMOR APOPTOSIS AS MAJOR DETERMINANT OF IMMUNOGENICITY$136,890
K08 · FY2005 · CA
TUMOR APOPTOSIS AS MAJOR DETERMINANT OF IMMUNOGENICITY$136,890
K08 · FY2004 · CA
TUMOR APOPTOSIS AS MAJOR DETERMINANT OF IMMUNOGENICITY$136,890
K08 · FY2003 · CA
TUMOR APOPTOSIS AS MAJOR DETERMINANT OF IMMUNOGENICITY$68,445
K08 · FY2002 · CA
TUMOR APOPTOSIS AS MAJOR DETERMINANT OF IMMUNOGENICITY$136,890
K08 · FY2001 · CA